Atai Beckley N.V.

ATAI · Nasdaq · SIC 2834: Pharmaceutical Preparations
99
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes. Founded in 2018, atai emerged from the urgent need for better mental health solutions for patients who are under-served by current treatment options. We are advancing a pipeline of product candidates designed to address the complex nature of mental health disorders. We believe that these investigational compounds have the potential t...

Next Earnings

Q2 FY2026 — expected 2026-09-21

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionATAIdiscussed_in_filing Cybersecurity
topic_mentionATAIdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-03-172024-12-310000950170-25-040244EDGAR146K words
2024-03-282023-12-310000950170-24-038138EDGAR—
2023-03-242022-12-310000950170-23-009756EDGAR—
2022-03-302021-12-310000950170-22-005013EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-277583EDGAR57K words
2025-08-142025-06-300000950170-25-108883EDGAR—
2025-05-142025-03-310000950170-25-071435EDGAR—
2024-11-132024-09-300000950170-24-126515EDGAR—
2024-08-132024-06-300000950170-24-096296EDGAR—
2024-05-152024-03-310000950170-24-060044EDGAR—
2023-11-142023-09-300000950170-23-063730EDGAR—
2023-08-102023-06-300000950170-23-041345EDGAR—
2023-05-112023-03-310000950170-23-021271EDGAR—
2022-11-102022-09-300000950170-22-024162EDGAR—
2022-08-152022-06-300000950170-22-017253EDGAR—
2022-05-162022-03-310000950170-22-009966EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-050001140361-25-044579EDGAR4K words
2025-11-120001140361-25-041546EDGAR—
2025-11-050001140361-25-040444EDGAR—
2025-11-050001140361-25-040429EDGAR—
2025-11-040001140361-25-040358EDGAR—
2025-10-270001140361-25-039317EDGAR—
2025-10-210001140361-25-038748EDGAR—
2025-10-200001140361-25-038525EDGAR—
2025-10-160001140361-25-038319EDGAR—
2025-10-100001140361-25-037941EDGAR—

99 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001840904
TickerATAI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedP7

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 35cffd26c64e4ff2a2165fbaf96cdef35b4af99add3847da030dacd4fdd985ce
parent: 01ae3baef9c75115c8453fe424866f1aa8f32d5312d6e099ccbce8c3d6c37742
content hash: e48f8d1ee2f0aa13ee27acfe67ee9a28e5158fed5abd77cc05d4a178bb1464a5
signed: 2026-04-13T04:43:46.204Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf